The London Times
Subscribe
  • August 22, 2026
  • Trending
    Trending
    To display trending posts, please ensure the Jetpack plugin is installed and that the Stats module of Jetpack is active. Refer to the theme documentation for help.
  • Search
    See all results
Latest
  • Latest
  • Oldest
  • Random
  • A to Z

Press Release

Press-Release-Coverage from around the Globe.

Valemetostat’s key data shows promising remission rates for adult T-cell leukemia/lymphoma patients – QNT Press Release

5 years ago

MaaT Pharma presented promising clinical data from 76 patients with acute graft-versus-host disease treated with MaaT013 at the 63rd ASH Annual Meeting – QNT Press Release

5 years ago

Open Head NFT provides a groundbreaking Ethereum lottery project to support transparency in the NFT space – QNT Press Release

5 years ago

AlloVir announced the positive preliminary data of Phase 2 of the ongoing Posoleucel polyvirus prevention study at the 63rd Annual Meeting of the American Society of Hematology – QNT Press Release

5 years ago

Novartis Kymriah® showed strong response to high-risk patients with relapsed or refractory follicular lymphoma during long-term study follow-up – QNT Press Release

5 years ago

CIEF 2021 kicked off and more than 6000 projects were exhibited online and offline ("Empowering the double cycle, boosting new development," 2021 CIEF opening) – QNT Press Release

5 years ago

Cellectis presented the encouraging clinical data from the BALLI-01 study of relapsed/refractory B-cell acute lymphoblastic leukemia and preclinical data from TALGlobin01 at the 63rd Annual Meeting of the American Society of Hematology – QNT Press Release

5 years ago

Schrödinger reported on the preclinical data supporting the progress of his MALT1 inhibitor program at the 2021 annual meeting of the American Society of Hematology – QNT Press Release

5 years ago

Phase 3 data proves that the combination of TIBSOVO® (ivosidenib tablets) and azacitidine can significantly improve the event-free survival and overall survival of patients with previously untreated IDH1 mutant acute myeloid leukemia – QNT Press Release

5 years ago

Phase 3 data proves that the combination of TIBSOVO® (ivosidenib tablets) and azacitidine can significantly improve the event-free survival and overall survival of patients with previously untreated IDH1 mutant acute myeloid leukemia – QNT Press Release

5 years ago

Soldo Blockchain is scheduled to launch on December 19, 2021 – QNT Press Release

5 years ago

CommLab India’s 2021 Hunger Mission provides food to 21,000 poor people in Hyderabad – QNT Press Release

5 years ago
Load More
All Rights Reserved - Theme by Codetipi
Back To Top
  • About Us
  • Latest
  • Privacy Policy
  • QNT – Home Page
  • Usage of Cookies Policy
  • Subscribe
Your go to resource for worldwide current affairs and news
2020 © Zeen World News
Start typing to see results or hit ESC to close
Covid-19 Crypto Currency Bitcoin real estate Amazon
See all results

Subscribe Now

Join millions of others and stay up to date with the latest developments.
[mc4wp_form id="682"]